logo

FX.co ★ Analytics #PFE | Pfizer Inc. Stock Price

Pharma vs. Indexes: Why Pfizer's Forecasts Are a Breath of Fresh Air

November Retail Sales Are Stronger Than Expected Pfizer Rising After 2025 Profit Forecast Dow Down for Ninth Day in a Row Indices Fall: Dow 0.61%, S&P 500 0.39%, Nasdaq 0.32%...
iconRelevance until19 December 2024 at 9:20AM (UTC+0)
Analytical expert: Thomas Frank
18 December 2024 at 9:20AM (UTC+0)

Pfizer posts better-than-expected quarterly revenue

Strong earnings reports of the world's largest corporations have triggered a positive reaction in the US stock market. Pfizer raised its earnings forecast for 2022 and beat its third-quarter expectations...
iconRelevance until2 November 2022 at 11:50AM (UTC+0)
Analytical expert: Jakub Novak
1 November 2022 at 11:55AM (UTC+0)

US premarket on May 23, 2022

During the S&P 500's dive on Friday, major market players quickly took advantage of an equity sell-off by panicked investors. The S&P 500 has lost 20% since the beginning...
iconRelevance until24 May 2022 at 11:52AM (UTC+0)
Analytical expert: Jakub Novak
23 May 2022 at 11:54AM (UTC+0)

Stock market situation on March 21

Purchases of Pfizer stocks (#PFE), a US based international pharmaceutical company. On the weekly chart, the price showed a considerable rise after a reversal from the support line...
iconRelevance until22 March 2022 at 2:50AM (UTC+0)
Analytical expert: Laurie Bailey
21 March 2022 at 4:51AM (UTC+0)

Buying and selling on the stock market on March 14

Purchase of Pfizer shares (#PFE). Biopharmaceutical company. On a weekly scale, the Pfizer stock price turned up from the MACD indicator line (blue), and if this is not a reversal...
iconRelevance until15 March 2022 at 2:39AM (UTC+0)
Analytical expert: Laurie Bailey
14 March 2022 at 4:14AM (UTC+0)

US Premarket on December 23: despite the end of the year, investors continue to take risks

Futures on US stock indices continued the growth observed yesterday, as investors stopped paying attention to concerns related to the Omicron strain. The strong fundamental statistics that were released yesterday...
iconRelevance until24 December 2021 at 11:31AM (UTC+0)
Analytical expert: Jakub Novak
23 December 2021 at 11:36AM (UTC+0)

Technical analysis of Pfizer for December 9, 2021

The major cup with handle pattern we pointed out back on August 4 has been triggered for a rally towards the Cup with handle target near 83.34. We are sure...
iconRelevance until10 December 2021 at 6:51AM (UTC+0)
Analytical expert: Torben Melsted
9 December 2021 at 6:51AM (UTC+0)

Pfizer - Cup with handle for August 4, 2021

On August 2 we saw the huge Cup with Handle formation that Pfizer has been building since 1999. All that was needed to trigger the formation was a break above...
iconRelevance until5 August 2021 at 5:32AM (UTC+0)
Analytical expert: Torben Melsted
4 August 2021 at 5:32AM (UTC+0)

Technical analysis of Pfizer for August 2, 2021

Pfizer is close to complete one of the most time-consuming "Cup with Handle" formation we have ever seen. A break above resistance at 44.05 will trigger the formation and call...
iconRelevance until3 August 2021 at 4:26AM (UTC+0)
Analytical expert: Torben Melsted
2 August 2021 at 4:26AM (UTC+0)

Buying and Selling in the Stock Market on March 19

Purchase of Pfizer (#PFE) shares. Pharmaceutical company. On the weekly chart, the price was fixed above the MACD indicator line after the previous five-week, but essentially had a false stay...
iconRelevance until20 March 2021 at 3:10AM (UTC+0)
Analytical expert: Laurie Bailey
19 March 2021 at 3:55AM (UTC+0)